EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Evoq Remedies's enterprise value is ₹254.72 Mil.
Evoq Remedies's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹20.56 Mil. Therefore, Evoq Remedies's EV-to-EBITDA for today is 12.39.
The historical rank and industry rank for Evoq Remedies's EV-to-EBITDA or its related term are showing as below:
BOM:543500'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.27 Med: 13.32 Max: 26.85
Current: 12.39
During the past 5 years, the highest EV-to-EBITDA of Evoq Remedies was 26.85. The lowest was 9.27. And the median was 13.32.
BOM:543500's EV-to-EBITDA is ranked worse than 66.67% of 81
companies
in the Medical Distribution industry
Industry Median: 9.36
vs BOM:543500: 12.39
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Evoq Remedies EV-to-EBITDA Historical Data
The historical data trend for Evoq Remedies's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Evoq Remedies's EV-to-EBITDA
For the Medical Distribution subindustry, Evoq Remedies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evoq Remedies's EV-to-EBITDA Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Evoq Remedies's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Evoq Remedies's EV-to-EBITDA falls into.
Evoq Remedies EV-to-EBITDA Calculation
Evoq Remedies's EV-to-EBITDA for today is calculated as:
Evoq Remedies's current Enterprise Value is ₹254.72 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evoq Remedies's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹20.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Evoq Remedies's PE Ratio for today is calculated as:
Evoq Remedies's share price for today is ₹9.74.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evoq Remedies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹1.006.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Evoq Remedies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:543500 has been successfully added to your